Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy?

R Ara, A Pandor, J Stevens, R Rafia, S Ward, A Rees, P Durrington, T Reynolds, A Wierzbicki, M Stevenson

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    JournalEur J Cardiovasc Prev Rehabil.
    Publication statusPublished - 1 Apr 2011

    Cite this